Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week
- Posted on March 27, 2026
- By CNBC
- 6 Views
Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week
The Swiss pharma giant is betting on a next-generation allergy treatment that may prove to work faster and better than anything currently on the market.
